Bid Banana
PricingBid helpAPILog inStart free trial
Log inStart free trial

Before you respond

  • Federal grantsHow to Find Grants for Nonprofits
  • Healthcare RFPsHealthcare and Medical Services Bids and Bidding Guide
  • How to apply for a grantGrant Applications vs. RFPs: Writing Differences Explained
More healthcare and medical services bids →Must-win bid? Bring in The Bid Lab →
Bid Banana
SearchPricingBid helpBrowse bidsAPISupportFAQPrivacy PolicyTerms of UseAI Use Policy

This website and its content is copyright of The Bid Lab © 2026. The Bid Lab is a trademark of Bid Lab, LLC. All rights reserved.

  1. Bid Banana
  2. ›Bids
  3. ›Federal
  4. ›Catalyze: Product Definition Medical Device Prototype…

U.S. National Institutes of Health·United States of America

Catalyze: Product Definition Medical Device Prototype Optimization (R33 - Clinical Trial Not Allowed)

Closes 12/23/2027$500k – $2MGrants Notice
Get bids like this by emailBid source

Description

The National Institutes of Health (NIH) is seeking applications for the Catalyze: Product Definition initiative, which aims to support the development of medical device prototypes for the treatment of heart, lung, and blood diseases. This initiative will provide funding for prototype testing and design modification, assay development, and research tool development. The goal is to transition basic science discoveries into viable diagnostic and therapeutic candidates. Key aspects of the job include: • Developing medical device prototypes • Conducting prototype testing and design modification • Developing assays for diagnostic disease targets • Creating research tools for the treatment of heart, lung, and blood diseases • Preparing products for in vivo testing and potential further support from NIH or other programs.

Attached files

Contact

[email protected]

(301) 402-2541

Key dates

Opened
11/22/2024
Closes
12/23/2027

Last updated

Details

Type
Grants Notice
Industry
Healthcare and Medical Services
NAICS
541710
Solicitation №
RFA-HL-26-020

Budget estimate

$500,000 – $2,000,000

The budget for this grant is not explicitly stated, but based on the information provided, it seems the funding will cover the costs associated with prototype development, testing, and design modification. The NIH typically provides funding in the range of $500,000 to $2 million for similar initiatives, depending on the scope and complexity of the project. Factors influencing the payment range include the number of applications received, the availability of funds, and the scientific merit of the proposed projects.

AI estimate from the solicitation

Similar opportunities

Matched by Bid Banana AI™

Bid Banana · 1.6M+ bids and awards 🍌

You found this one. Bid Banana has 1.6M+ bids and awards.

You found this bid by looking. Bid Banana searches open government bids across all 50 states, updated daily, so you stop hunting: save a search once and we email you your new matches, daily or weekly.

1.6M+
bids & awards
All 50
states
4,000+
agencies
Start your 7-day free trial

Plans from $49.99/month. Cancel anytime, no setup fees.

Built by The Bid Lab, answering RFPs since 2017.

U.S. National Institutes of Health·United States of America

Top match · 96%

Catalyze Product Definition Medical Device prototype design/testing and disease target identification and assay development (R61/R33 - Clinical Trial Not Allowed)

Closes 12/23/2027Opened 11/22/2024

U.S. National Institutes of Health·United States of America

93% match

Catalyze: Product Definition for Small Molecules, Biologics, and Combination Products - Preliminary Product/Lead Series Identification and Combination Product Prototype (R33 - Clinical Trial Not Allowed)

Closes 12/23/2027Opened 11/22/2024

U.S. National Institutes of Health·United States of America

92% match

Catalyze: Product Definition for Small Molecules, Biologics and Combination Products - Target Identification and Validation, and Preliminary Product/Lead Series Identification (R61/R33 Clinical Trials Not Allowed)

Closes 12/23/2027Opened 11/22/2024

U.S. National Institutes of Health·United States of America

86% match

Catalyze: Enabling Technologies and Transformative Platforms for HLBS Research (R33 - Clinical Trials Not Allowed)

Closes 12/23/2027Opened 1/24/2022

U.S. National Institutes of Health·United States of America

78% match

NextTech: Translational Development of Next-Generation Diagnostic and Therapeutic Devices (R18 Clinical Trial Not Allowed)

Closes 12/1/2030Opened 2/27/2026

U.S. National Institutes of Health·United States of America

78% match

Development of Models, New Approach Methodologies, and Biological Materials for Studying Human Health and Diseases (R21 Clinical Trial Not Allowed)

Closes 2/15/2028Opened 9/16/2026

U.S. National Institutes of Health·United States of America

77% match

Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)

Closes 11/10/2026Opened 9/8/2025

U.S. National Institutes of Health·United States of America

77% match

Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)

Closes 6/3/2027Opened 7/14/2026

U.S. National Institutes of Health·United States of America

77% match

Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Assay Development and Neurotherapeutic Agent Identification (R61/R33 Clinical Trial Not Allowed)

Closes 10/20/2027Opened 10/22/2024

U.S. National Institutes of Health·United States of America

77% match

Technology Development Program

Closes 2/4/2028Opened 9/16/2026

U.S. National Institutes of Health·United States of America

77% match

Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)

Closes 6/3/2027Opened 7/14/2026

U.S. National Institutes of Health·United States of America

76% match

NCCIH Natural Product Early Phase Clinical Trial Phased Innovation Award (R61/R33 Clinical Trial Required)

Closes 11/13/2026Opened 2/1/2024

U.S. National Institutes of Health·United States of America

76% match

BRAIN Initiative: Reagent Resources for Brain Cell Type-Specific Access to Broaden Distribution of Enabling Technologies for Neuroscience (U24 Clinical Trial Not Allowed)

Closes 6/15/2027Opened 9/25/2024

U.S. National Institutes of Health·United States of America

76% match

Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)

Closes 11/10/2026Opened 9/8/2025

U.S. Department Of Energy·Ohio

76% match

TECHNOLOGY LICENSING OPPORTUNITY: Clathrate Therapeutics Platform

Closes 12/3/2026Opened 6/4/2026

U.S. National Institutes of Health·United States of America

76% match

HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allowed)

Closes 1/15/2027Opened 9/18/2024

U.S. National Institutes of Health·United States of America

76% match

Early Stage Testing of Pharmacologic or Neuromodulatory Device-based Interventions for the Treatment of Mental Disorders (R33- Clinical Trial Required)

Closes 10/15/2027Opened 11/26/2024

U.S. National Institutes of Health·United States of America

76% match

Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Neurotherapeutic Agent Characterization and In vivo Efficacy Studies (R61/R33 Clinical Trial Not Allowed)

Closes 10/20/2027Opened 10/22/2024

U.S. Department Of Health And Human Services·United States of America

75% match

Pre-Clinical Models of Infectious Diseases

Closes 12/7/2026Opened 10/19/2026

U.S. National Institutes of Health·United States of America

75% match

Bioengineering Partnerships with Industry (U01 Clinical Trial Optional)

Closes 9/7/2027Opened 3/8/2022

U.S. National Institutes of Health·United States of America

75% match

Expanding the Target Landscape by Drugging the Undruggable (R21 Clinical Trial Not Allowed)

Closes 2/17/2028Opened 5/28/2025

U.S. National Institutes of Health·United States of America

75% match

CCRP Initiative: Promoting a Basic Understanding of Chemical Threats to Skin (R01 Clinical Trial Not Allowed)

Closes 11/5/2028Opened 6/30/2025

U.S. National Institutes of Health·United States of America

75% match

NEI Translational Research Program for Therapeutics (R61/R33 Clinical Trial Not Allowed)

Closes 11/16/2029Opened 9/9/2025

U.S. National Institutes of Health·United States of America

75% match

Resource-Related Research Projects for Development of Models and Related Materials for Studying Human Health and Diseases (R24 Clinical Trials Not Allowed)

Closes 9/28/2028Opened 6/9/2025

U.S. National Institutes of Health·United States of America

75% match

Translational Centers Using Microphysiological Systems for Infectious Diseases (U54 Clinical Trial Not Allowed)

Closes 1/29/2027Opened 6/24/2026